Home > Key Markets in Medicare Part D (Table of Contents)

Key Markets in Medicare Part D

Decision Resources
August 28, 2008
47 Pages - SKU: DECR1904351

Abstract Table of Contents Related Reports

Executive Summary: Strategic Considerations; Stakeholder Implications
Introduction
Methodology
Key Medicare Part D Therapeutic Areas: Cardiovascular Disorders; Metabolic Disorders; Infectious Diseases; Immune/Infl ammatory Disorders; Other Common Indications
Formularies and Medicare Part D: Medicare Part D Plans and Evolving Formulary Design; Coverage of Cardiovascular Drugs; Coverage of Metabolic Drugs; Coverage of Infectious Disease Therapies; Coverage of Immune/Infl ammatory Drugs; Coverage of Treatments for Other Common Indications
The Outlook for Medicare Part D: Sustained Growth of the Medicare Population; Regulatory Reforms; Changing Political Climate
Tables: 1. Select Brand-Name Cardiovascular Drugs with 2007 U.S. Sales; 2. Select Brand-Name Metabolic Drugs with 2007 U.S. Sales; 3. Select Brand-Name Anti-Infectives with 2007 U.S. Sales; 4. Select Brand-Name Immune/Infl ammatory Drugs with 2007 U.S. Sales; 5. Select Brand-Name “Other” Drugs with 2007 U.S. Sales; 6. Available Medicare Part D Formulary Coverage and Restrictions for Cardiovascular Drugs; 7. Available Medicare Part D Formulary Copay and Coinsurance Data for Cardiovascular Drugs; 8. Available Medicare Part D Formulary Coverage and Restrictions for Metabolic Drugs; 9. Available Medicare Part D Formulary Copay and Coinsurance Data for Metabolic Drugs; 10. Available Medicare Part D Formulary Coverage and Restrictions for Anti-Infectives; 11. Available Medicare Part D Formulary Copay and Coinsurance Data for Anti-Infectives; 12. Available Medicare Part D Formulary Coverage and Restrictions for Immune/Infl ammatory Drugs; 13. Available Medicare Part D Formulary Copay and Coinsurance Data for Immune/Infl ammatory Drugs; 14. Available Medicare Part D Formulary Coverage and Restrictions for “Other” Indication Drugs; 15. Available Medicare Part D Formulary Copay and Coinsurance Data for “Other” Indication Drugs
Figures: 1. U.S. Pharmaceutical Expenditures by Source of Funding, 2000-2017 (Projected); 2. Share of U.S. Pharmaceutical Expenditures by Source of Funding, 2000-2017 (Projected); 3. Medicare Benefi ciaries’ Sources of Prescription Drug Benefi ts as of January 2008; 4. Hypertension Patients, Aged 65 or Older, by Prescription Drug Insurance Type, 2006 and 2007; 5. Top Hypertension Drugs Prescribed to Medicare Part D Patients, Aged 65 or Older, 2006 and 2007; 6. Atrial Fibrillation Patients, Aged 65 or Older, by Prescription Drug Insurance Type, 2006 and 2007; 7. Top Atrial Fibrillation Drugs Prescribed to Medicare Part D Patients, Aged 65 or Older, 2006 and 2007; 8. Coronary Atherosclerosis Patients, Aged 65 or Older, by Prescription Drug Insurance Type, 2006 and 2007; 9. Top Coronary Atherosclerosis Drugs Prescribed to Medicare Part D Patients, Aged 65 or Older, 2006 and 2007; 10. Congestive Heart Failure Patients, Aged 65 or Older, by Prescription Drug Insurance Type, 2006 and 2007; 11. Top Congestive Heart Failure Drugs Prescribed to Medicare Part D Patients, Aged 65 or Older, 2006 and 2007; 12. Dyslipidemia Patients, Aged 65 or Older, by Prescription Drug Insurance Type, 2006 and 2007; 13. Top Dyslipidemia Drugs Prescribed to Medicare Part D Patients, Aged 65 or Older, 2006 and 2007; 14. Type 2 Diabetes Patients, Aged 65 or Older, by Prescription Drug Insurance Type, 2006 and 2007; 15. Top Type 2 Diabetes Drugs Prescribed to Medicare Part D Patients, Aged 65 or Older, 2006 and 2007; 16. Osteoporosis Patients, Aged 65 or Older, by Prescription Drug Insurance Type, 2006 and 2007; 17. Top Osteoporosis Drugs Prescribed to Medicare Part D Patients, Aged 65 or Older, 2006 and 2007; 18. Bronchitis Patients, Aged 65 or Older, by Prescription Drug Insurance Type, 2006 and 2007; 19. Top Bronchitis Drugs Prescribed to Medicare Part D Patients, Aged 65 or Older, 2006 and 2007; 20. Pneumonia Patients, Aged 65 or Older, by Prescription Drug Insurance Type, 2006 and 2007; 21. Top Pneumonia Drugs Prescribed to Medicare Part D Patients, Aged 65 or Older, 2006 and 2007; 22. Chronic Sinusitis Patients, Aged 65 or Older, by Prescription Drug Insurance Type, 2006 and 2007; 23. Top Chronic Sinusitis Drugs Prescribed to Medicare Part D Patients, Aged 65 or Older, 2006 and 2007; 24. Urinary Tract Infection Patients, Aged 65 or Older, by Prescription Drug Insurance Type, 2006 and 2007; 25. Top Urinary Tract Infection Drugs Prescribed to Medicare Part D Patients, Aged 65 or Older, 2006 and 2007; 26. Osteoarthritis Patients, Aged 65 or Older, by Prescription Drug Insurance Type, 2006 and 2007; 27. Top Osteoarthritis Drugs Prescribed to Medicare Part D Patients, Aged 65 or Older, 2006 and 2007; 28. Chronic Airway Obstruction Patients, Aged 65 or Older, by Prescription Drug Insurance Type, 2006 and 2007; 29. Top Chronic Airway Obstruction Drugs Prescribed to Medicare Part D Patients, Aged 65 or Older, 2006 and 2007; 30. Cataract Patients, Aged 65 or Older, by Prescription Drug Insurance Type, 2006 and 2007; 31. Top Cataract Drugs Prescribed to Medicare Part D Patients, Aged 65 or Older, 2006 and 2007; 32. Glaucoma Patients, Aged 65 or Older, by Prescription Drug Insurance Type, 2006 and 2007; 33. Top Glaucoma Drugs Prescribed to Medicare Part D Patients, Aged 65 or Older, 2006 and 2007; 34. Benign Prostatic Hyperplasia Patients, Aged 65 or Older, by Prescription Drug Insurance Type, 2006 and 2007; 35. Top Benign Prostatic Hyperplasia Drugs Prescribed to Medicare Part D Patients, Aged 65 or Older, 2006 and 2007; 36. Past and Projected Enrollment in the Medicare Program, 2006-2030

Research assistance

We can help you find what you need. Call us or write us:

US: 800.298.5699

Int'l: +1.240.747.3093

Need help in your search?

Related Markets

Medicare & Medicaid Reports

Share this report

Email a colleague

Other tasks

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!